Battling Lung Cancer With Combination Drug TherapyCombination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI). The study, "STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma," was published online by the Public Library of Science (PLoS) ONE...
Men With Reduced Fertility At Reduced Risk For Prostate CancerInvoluntary childlessness owing to reduced fertility is a concern for many men. However, these men do have one advantage - they run a significantly lower risk of suffering from prostate cancer. Researchers are interested in whether this phenomenon could be used in the fight against cancer. There is a clear link between male subfertility and a lower risk of prostate cancer...
New Vaccine Approach Discovered For The Treatment Of CancerScientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental Immunology at Trinity College Dublin discovered a new approach for treating the disease based on manipulating the immune response to malignant tumours...
Brachytherapy Lowers Prostate Cancer MortalityAccording to a study from radiation oncologists at the Kimmel Cancer Center at Jefferson, high-risk prostate cancer patients who receive brachytherapy, alone or together with external beam radiation therapy (EBRT) had considerably lower mortality rates. The study is published online January 23 in the International Journal of Radiation Oncology*Biology*Physics...
Prostate Cancer - Evidence Not Beliefs Matter Regarding Screening And TreatmentAccording to Beth Israel Deaconess Medical Center and prostate expert Marc B. Garnick, MD, physicians who advise PSA tests for men being screened for prostate cancer must base their decision more on available evidence when recommending screening, biopsies and treatments, instead of holding on to long held beliefs that PSA-based testing benefits all...
Dutasteride Slows Down Early Stage Prostate Cancer ProgressionA study published Online First in The Lancet has found that a common medication (dutasteride) used to treat enlargement of the prostate, may also reduce the need for treatments that pose risks of incontinence and impotence and delay growth of early-stage prostate cancer...
Risk Of Nerve Damage In Prostate Cancer Surgeries May Be Reduced By Preoperative MRIPreoperative MRI helps surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer, according to a new study published online in the journal Radiology. Excluding skin cancer, prostate cancer is the most common cancer diagnosed in American men, according to the Centers for Disease Control and Prevention...
Stopping Prostate Cancer Growth - Breakthrough A study by investigators at the Methodist Research Institute at Indiana University confirms that an all-natural, doctor-designed formula is effective in suppressing prostate cancer tumors. The study conducted on mice, used a human prostate cancer xenograft model. Results from the live animal study were presented by lead researcher, Dr...
How Obesity Affects Cancer ScreeningResearchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women...